Researchers discussing opportunities in biomanufacturing

The manufacturing of biological products such as tissues, cells, small molecules, therapeutic proteins, vaccines, and biologic delivery devices is currently highly inefficient with little to no automation and generates tremendous waste products.

Georgia Tech was a founding member of President Obama’s Advanced Manufacturing Partnership (AMP 1.0) initiative. Biomanufacturing was one of the top cross-cutting technologies specifically identified by the AMP 1.0 steering committee.

Georgia Tech is uniquely positioned for a major initiative focused on biomanufacturing because of its combined strengths in manufacturing, bioengineering, robotics and systems engineering.

All interested parties are welcomed to attend, this includes faculty, graduate students and post-docs. 

Program

8:30am - Introductory Comments

8:45am - Jon Rowley - RoosterBio
Innovation Trends in Therapeutic Cell Manufacturing

9:15am - Brian Murphy - Celgene
Process Development of an Allogeneic Cryopreserved Cell Therapy

9:45am Break

10:10am - Andy Bommarius - Georgia Tech
The Role of Downstream Processing and Formulation in the Manufacturing of Biologics

10:30am - Todd McDevitt - Georgia Tech
Advanced Technologies for Manufacturing of Cell Products

10:50am - Krish Roy - Georgia Tech
Biomanufacturing: From T Cell Immunotherapy to Nanofabrication

11:10am - Mark Prausnitz - Georgia Tech
Microneedle Patch Manufacturing for a Phase 1 Clinical Trial of Influenza Vaccination

11:30am - Ian Copland - Emory University
Emory Personalized Immunotherapy Center: Enabling Cell Therapies in Georgia

11:50am - Leon McGinnis - Georgia Tech
Model-Based Biomanufacturing Systems Engineering

12:10pm - Heni Ben Amor - Georgia Tech
The Role of Automation in Cell Manufacturing

VIEW PROGRAM ONLINE
REGISTER